![]() |
![]() Bruce Herring B.S., University of Texas, Austin email: bherring at uchicago dot edu Advisor: Aaron Fox |
|
General
anesthetics (GAs) are known to suppress central nervous system activity
in part
through the activation/facilitation of postsynaptic GABA(A) receptors.
While
GABA(A) receptors do contribute to anesthetic action, GAs also
influence
presynaptic mechanisms as well. Most studies, however, have focused
almost
exclusively on presynaptic ion channels. Although indirect, previous
experiments performed in my lab have indicated that the GAs etomidate
and
isoflurane inhibit the neurotransmitter release machinery directly.
Amperometric data I have since collected from permeabilized PC12 cells
suggests
that etomidate is, in fact, capable of inhibiting the release of
catecholamines
via a direct interaction with the mammalian release machinery. My
proposal aims
to combine molecular, electrophysiological and electron microscope
(EM)-based
experiments to further test this hypothesis as well as identify the
components
of the release machinery that are involved in the response to GAs. To
determine
if the inhibition of the release machinery represents a universal
property of
GAs I will also investigate whether isoflurane affects neurotransmitter
release
from permeabilized PC12 cells. I will then employ photolysis of caged
calcium
to more accurately characterize the effects of isoflurane on the
release
machinery in PC12 cells. This technique allows for better control of
the
duration and magnitude of increases in [Ca2+]i
and will
allow cells to serve as their own controls. I will also determine
whether
syntaxin 1A or its activator, UNC-13, are involved in mediating the
effects of
GAs in mammalian cells. This will be done by replacing the endogenous
forms of
these proteins with mutants previously found to influence GA
sensitivity in C.
elegans. The effects of isoflurane on vesicular trafficking will also
be
investigated using EM. Together, these experiments have the potential
to
identify the release machinery as an important new target for GAs. If
anesthetics were to inhibit glutamate (or other neurotransmitters)
release at
central synapses via this mechanism, this would provide vital
information for
designing new anesthetics. |
|
Committee on Neurobiology | University of Chicago |
| 04/10/08 |